Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Tango Therapeutics, Inc. (TNGX)

NASDAQ

$23,89

$-0,63

(-2,57%)

Pre-Market

Tango Therapeutics, Inc. (TNGX) Live Price Chart

Last updated: ⁦2026-09-16 09:05:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Tango Therapeutics, Inc. (TNGX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $23,89, with a market capitalisation of $4,14B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6,69 to $34,39. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4,14B
Open	$24,55
Day's High	$34,39
Day's Low	$1,03
Previous Close	$24,54
Volume	1,27M
Average Volume	3,02M
P/E Ratio	--
52-Week High	$34,39
52-Week Low	$6,69
Dividend Yield	--
Earnings Date	--

Tango Therapeutics, Inc. (TNGX) Pre-Market Stock Price

Tango Therapeutics, Inc. (TNGX) is trading at $24,63 in pre-market trading as of 2026-09-15 23:31:00, up 0,35% ($0,09) from the previous close of $24,54

Pre-market trading shows how investors are pricing TNGX before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Tango Therapeutics, Inc. (TNGX) 7-Day Stock Price Change

Over the past seven days, Tango Therapeutics, Inc. (TNGX) moved from $22,52 to $23,89, representing a gain of 6,06% ($1,37).

The stock traded between $22,26 and $25,52 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.

The average daily volume was 2,58 million shares, up versus the previous seven-day period, indicating higher trading activity.

TNGX 52-Week Price Position

Position in Range: 62,1%

52W Low$6,69

52W High$34,39

TNGX is currently trading at $23,89, placing it 62,1% of the way from its 52-week low of $6,69 to its 52-week high of $34,39. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Tango Therapeutics, Inc. (TNGX)?

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Tango Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	137
Exchange	NASDAQ
Company Website	https://www.tangotx.com

How to Buy Tango Therapeutics, Inc. (TNGX) Stock on MEXC

Eligible investors can buy real shares of Tango Therapeutics, Inc. (TNGX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TNGX and Place Your Order

Open the RealStocks trading page and search for TNGX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Tango Therapeutics, Inc. (TNGX) stock price today?

Tango Therapeutics, Inc. (TNGX) is currently trading at $ 23,89, down 2,67% ($0,65) from the previous close of $ 24,54. Intraday prices update in real time during regular trading hours.

2.Is TNGX stock going up or down today?

As of 2026-09-15 23:31:00, TNGX is trading at $ 23,89, down 2,67% ($0,65) from its previous close of $ 24,54. The stock has traded between $ 1,03 and $ 34,39 during today’s regular session. Past price movements do not guarantee future results.

3.What is TNGX pre-market price?

As of 2026-09-15 23:31:00, TNGX is trading at $ 24,63 in pre-market trading, up 0,35% ($0,09) from the previous close of $ 24,54. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TNGX after-hours price?

As of 2026-09-15 23:31:00, TNGX is trading at $ 23,89 in after-hours trading, down 2,67% ($0,65) from the regular-session close of $ 24,54. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TNGX stock trading now?

TNGX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TNGX sit relative to its 52-week high and low?

Over the past 52 weeks, TNGX has traded between a low of $ 6,69 and a high of $ 34,39. At $ 23,89, the stock is positioned 62,1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Tango Therapeutics, Inc. in?

Tango Therapeutics, Inc. (TNGX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Tango Therapeutics, Inc.'s market capitalisation and where is it listed?

Tango Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 4,14B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TNGX valued in terms of P/E ratio and EPS?

TNGX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0,73. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Tango Therapeutics, Inc. pay a dividend?

Tango Therapeutics, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.